Scleroderma associated with ANCA-associated vasculitis

Rheumatology International

Volumn 26, Issue 5, 2006, Pages 465-468

  Young, Hee Rho ^a   Seong, Jae Choi ^b   Young, Ho Lee ^b   Jong, Dae Ji ^a   Song, Gwan Gyu ^b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

ANCA; Scleroderma; Vasculitis

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; PREDNISONE; PROSTAGLANDIN E1; STEROID;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FAILURE; KOREA; LUNG FIBROSIS; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PROTEINURIA; SCLERODERMA; STEROID THERAPY; TREATMENT OUTCOME; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VASCULITIS;

EID: 33644625165     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0003-5     Document Type: Article

References (16)

1. Endo H, Hosono T, Kondo H (1994) Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21:864-870
2. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352-357
3. Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613-1619
4. Donohoe JF (1992) Scleroderma and the kidney. Kidney Int 41:462-477
5. Katrib A, Sturgess A, Bertouch JV (1999) Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19:61-63
6. Casari S, Haeney M, Farrand S, Herrick A (2002) Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis. J Rheumatol 29:2666-2667
7. Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H et al (1997) Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies - related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 36:508-513
8. Homma S, Matsushita H, Nakata K (2004) Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9:190-196
9. Lhote F, Cohen P, Genereau T, Gayraud M, Guillevin L (1996) Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris) 147:165-177
10. Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104:7-16
11. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE (1990) Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65:847-856
12. Eschun GM, Mink SN, Sharma S (2003) Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123:297-301
13. Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M et al (2002) Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 29:918-923
14. Kiraz S, Simsek H, Ertenli I, Benekli M, Kadayifci A (1996) Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clin Rheumatol 15:519-520
15. Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM (2002) Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine 69:177-180
16. Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30:1248-1252